The U.S. Food and Drug Administration Approved an Experimental Alzheimer's Drug That Aims ... - Latest Tweet by Reuters

The U.S. Food and Drug Administration approved an experimental Alzheimer's drug that aims to slow the advance of the neurodegenerative disease by removing sticky clumps of the toxic protein beta amyloid from the brain https://t.co/4RaXCKpz09 pic.twitter.com/w4u1yiTtl6— Reuters (@Reuters) January 7, 2023

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)